Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2007

Open Access 01-08-2007 | Research article

Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile

Authors: Christine Lyn Le Maitre, Judith Alison Hoyland, Anthony J Freemont

Published in: Arthritis Research & Therapy | Issue 4/2007

Login to get access

Abstract

Low back pain is a common and debilitating disorder. Current evidence implicates intervertebral disc (IVD) degeneration and herniation as major causes, although the pathogenesis is poorly understood. While several cytokines have been implicated in the process of IVD degeneration and herniation, investigations have predominately focused on Interleukin 1 (IL-1) and tumor necrosis factor alpha (TNFα). However, to date no studies have investigated the expression of these cytokines simultaneously in IVD degeneration or herniation, or determined which may be the predominant cytokine associated with these disease states. Using quantitative real time PCR and immunohistochemistry we investigated gene and protein expression for IL-1β, TNFα and their receptors in non-degenerate, degenerate and herniated human IVDs. IL-1β gene expression was observed in a greater proportion of IVDs than TNFα (79% versus 59%). Degenerate and herniated IVDs displayed higher levels of both cytokines than non-degenerate IVDs, although in degenerate IVDs higher levels of IL-1β gene expression (1,300 copies/100 ng cDNA) were observed compared to those of TNFα (250 copies of TNFα/100 ng cDNA). Degenerate IVDs showed ten-fold higher IL-1 receptor gene expression compared to non-degenerate IVDs. In addition, 80% of degenerate IVD cells displayed IL-1 receptor immunopositivity compared to only 30% of cells in non-degenerate IVDs. However, no increase in TNF receptor I gene or protein expression was observed in degenerate or herniated IVDs compared to non-degenerate IVDs. We have demonstrated that although both cytokines are produced by human IVD cells, IL-1β is expressed at higher levels and in more IVDs, particularly in more degenerate IVDs (grades 4 to 12). Importantly, this study has highlighted an increase in gene and protein production for the IL-1 receptor type I but not the TNF receptor type I in degenerate IVDs. The data thus suggest that although both cytokines may be involved in the pathogenesis of IVD degeneration, IL-1 may have a more significant role than TNFα, and thus may be a better target for therapeutic intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A: Low back pain in relation to lumbar disc degeneration. Spine. 2000, 25: 487-492. 10.1097/00007632-200002150-00016.CrossRefPubMed Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A: Low back pain in relation to lumbar disc degeneration. Spine. 2000, 25: 487-492. 10.1097/00007632-200002150-00016.CrossRefPubMed
2.
go back to reference Maniadakis N, Gray A: The economic burden of back pain in the UK. Pain. 2000, 84: 95-103. 10.1016/S0304-3959(99)00187-6.CrossRefPubMed Maniadakis N, Gray A: The economic burden of back pain in the UK. Pain. 2000, 84: 95-103. 10.1016/S0304-3959(99)00187-6.CrossRefPubMed
3.
go back to reference Krismer M, van Tulder M: Low back pain (non-specific). Best Pract Res Clin Rheumatol. 2007, 21: 77-91. 10.1016/j.berh.2006.08.004.CrossRefPubMed Krismer M, van Tulder M: Low back pain (non-specific). Best Pract Res Clin Rheumatol. 2007, 21: 77-91. 10.1016/j.berh.2006.08.004.CrossRefPubMed
4.
go back to reference Weiler C, Nerlich A, Zipperer J, Bachmeier BE, Boos N: 2002 SSE Award Competition in Basic Science: Expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J. 2002, 11: 308-320. 10.1007/s00586-002-0472-0.PubMedCentralCrossRefPubMed Weiler C, Nerlich A, Zipperer J, Bachmeier BE, Boos N: 2002 SSE Award Competition in Basic Science: Expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J. 2002, 11: 308-320. 10.1007/s00586-002-0472-0.PubMedCentralCrossRefPubMed
5.
go back to reference Le Maitre CL, Freemont AJ, Hoyland JA: Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004, 204: 47-54. 10.1002/path.1608.CrossRefPubMed Le Maitre CL, Freemont AJ, Hoyland JA: Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004, 204: 47-54. 10.1002/path.1608.CrossRefPubMed
6.
go back to reference Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002, 55: 91-97. 10.1136/mp.55.2.91.PubMedCentralCrossRefPubMed Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002, 55: 91-97. 10.1136/mp.55.2.91.PubMedCentralCrossRefPubMed
7.
go back to reference Le Maitre CL, Freemont A, Hoyland J: Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem. 2006, 81: 125-131. 10.1080/10520290601005298.CrossRefPubMed Le Maitre CL, Freemont A, Hoyland J: Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem. 2006, 81: 125-131. 10.1080/10520290601005298.CrossRefPubMed
8.
go back to reference Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS: mRNAexpression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine. 2002, 27: 911-917. 10.1097/00007632-200205010-00005.CrossRefPubMed Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS: mRNAexpression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine. 2002, 27: 911-917. 10.1097/00007632-200205010-00005.CrossRefPubMed
9.
go back to reference Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH: Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1995, 20: 2373-2378. 10.1097/00007632-199511001-00001.CrossRefPubMed Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH: Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1995, 20: 2373-2378. 10.1097/00007632-199511001-00001.CrossRefPubMed
10.
go back to reference Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF, Evans CH: Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1996, 21: 271-277. 10.1097/00007632-199602010-00003.CrossRefPubMed Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF, Evans CH: Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1996, 21: 271-277. 10.1097/00007632-199602010-00003.CrossRefPubMed
11.
go back to reference Le Maitre CL, Richardson SMA, Williamson B, Ross R, Freemont AJ, Hoyland JA: IL-1: role in degeneration of the intervertebraldisc and its inhibition using IL-1Ra gene transfer. Mol Therapy. 2003, 5: S405- Le Maitre CL, Richardson SMA, Williamson B, Ross R, Freemont AJ, Hoyland JA: IL-1: role in degeneration of the intervertebraldisc and its inhibition using IL-1Ra gene transfer. Mol Therapy. 2003, 5: S405-
12.
go back to reference Le Maitre CL, Freemont AJ, Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005, 7: R732-R745. 10.1186/ar1732.PubMedCentralCrossRefPubMed Le Maitre CL, Freemont AJ, Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005, 7: R732-R745. 10.1186/ar1732.PubMedCentralCrossRefPubMed
13.
go back to reference Doita M, Kanatani T, Harada T, Mizuno K: Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine. 1996, 21: 235-241. 10.1097/00007632-199601150-00015.CrossRefPubMed Doita M, Kanatani T, Harada T, Mizuno K: Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine. 1996, 21: 235-241. 10.1097/00007632-199601150-00015.CrossRefPubMed
14.
go back to reference Takahashi H, Suguro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T: Inflammatory cytokines in the herniated disc of the lumbar spine. Spine. 1996, 21: 218-224. 10.1097/00007632-199601150-00011.CrossRefPubMed Takahashi H, Suguro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T: Inflammatory cytokines in the herniated disc of the lumbar spine. Spine. 1996, 21: 218-224. 10.1097/00007632-199601150-00011.CrossRefPubMed
15.
go back to reference Igarashi T, Kikuchi S, Shubayev V, Myers RR: 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine. 2000, 25: 2975-2980. 10.1097/00007632-200012010-00003.CrossRefPubMed Igarashi T, Kikuchi S, Shubayev V, Myers RR: 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine. 2000, 25: 2975-2980. 10.1097/00007632-200012010-00003.CrossRefPubMed
16.
go back to reference Olmarker K, Larsson K: Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine. 1998, 23: 2538-2544. 10.1097/00007632-199812010-00008.CrossRefPubMed Olmarker K, Larsson K: Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine. 1998, 23: 2538-2544. 10.1097/00007632-199812010-00008.CrossRefPubMed
17.
go back to reference Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K: Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion. Spine. 2004, 29: 2477-2484. 10.1097/01.brs.0000144406.17512.ea.CrossRefPubMed Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K: Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion. Spine. 2004, 29: 2477-2484. 10.1097/01.brs.0000144406.17512.ea.CrossRefPubMed
18.
go back to reference Larsson K, Rydevik B, Olmarker K: Disc related cytokinesinhibit axonal outgrowth from dorsal root ganglion cells in vitro. Spine. 2005, 30: 621-624. 10.1097/01.brs.0000155410.48700.9e.CrossRefPubMed Larsson K, Rydevik B, Olmarker K: Disc related cytokinesinhibit axonal outgrowth from dorsal root ganglion cells in vitro. Spine. 2005, 30: 621-624. 10.1097/01.brs.0000155410.48700.9e.CrossRefPubMed
19.
go back to reference Murata Y, Onda A, Rydevik B, Takahashi I, Takahashi K, Olmarker K: Changes in pain behavior and histologic changes caused by application of tumor necrosis factor-alpha to the dorsal root ganglion in rats. Spine. 2006, 31: 530-535. 10.1097/01.brs.0000201260.10082.23.CrossRefPubMed Murata Y, Onda A, Rydevik B, Takahashi I, Takahashi K, Olmarker K: Changes in pain behavior and histologic changes caused by application of tumor necrosis factor-alpha to the dorsal root ganglion in rats. Spine. 2006, 31: 530-535. 10.1097/01.brs.0000201260.10082.23.CrossRefPubMed
20.
go back to reference Cooper RG, Freemont AJ: TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last?. Rheumatology (Oxford). 2003, 43 (2): 119-21. 10.1093/rheumatology/keh013.CrossRef Cooper RG, Freemont AJ: TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last?. Rheumatology (Oxford). 2003, 43 (2): 119-21. 10.1093/rheumatology/keh013.CrossRef
21.
go back to reference Weiler C, Nerlich AG, Bachmeier BE, Boos N: Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine. 2005, 30: 44-53. 10.1097/01.brs.0000174529.07959.c0.CrossRefPubMed Weiler C, Nerlich AG, Bachmeier BE, Boos N: Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine. 2005, 30: 44-53. 10.1097/01.brs.0000174529.07959.c0.CrossRefPubMed
22.
go back to reference Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann NY Acad Sci. 2007, 1096: 44-54. 10.1196/annals.1397.069.CrossRefPubMed Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann NY Acad Sci. 2007, 1096: 44-54. 10.1196/annals.1397.069.CrossRefPubMed
23.
go back to reference Le Maitre CL, Freemont AJ, Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007, 9: R45-10.1186/ar2198.PubMedCentralCrossRefPubMed Le Maitre CL, Freemont AJ, Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007, 9: R45-10.1186/ar2198.PubMedCentralCrossRefPubMed
24.
go back to reference Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brian JP, Hoyland JA: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002, 197: 286-292. 10.1002/path.1108.CrossRefPubMed Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brian JP, Hoyland JA: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002, 197: 286-292. 10.1002/path.1108.CrossRefPubMed
25.
go back to reference Seguin CA, Pilliar RM, Roughley PJ, Kandel RA: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine. 2005, 30: 1940-1948. 10.1097/01.brs.0000176188.40263.f9.CrossRefPubMed Seguin CA, Pilliar RM, Roughley PJ, Kandel RA: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine. 2005, 30: 1940-1948. 10.1097/01.brs.0000176188.40263.f9.CrossRefPubMed
26.
go back to reference Abe Y, Akeda K, An HS, Aoki Y, Pichika R, Muehleman C, Kimura T, Masuda K: Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine. 2007, 32: 635-642. 10.1097/01.brs.0000257556.90850.53.CrossRefPubMed Abe Y, Akeda K, An HS, Aoki Y, Pichika R, Muehleman C, Kimura T, Masuda K: Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine. 2007, 32: 635-642. 10.1097/01.brs.0000257556.90850.53.CrossRefPubMed
27.
go back to reference Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P: Pathophysiology of disk-related sciatica. I. – Evidence supporting a chemical component. Joint Bone Spine. 2006, 73: 151-158. 10.1016/j.jbspin.2005.03.003.CrossRefPubMed Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P: Pathophysiology of disk-related sciatica. I. – Evidence supporting a chemical component. Joint Bone Spine. 2006, 73: 151-158. 10.1016/j.jbspin.2005.03.003.CrossRefPubMed
28.
go back to reference Tobinick E, Britschgi-Davoodifar S: Perispinal TNF-alpha inhibition for discogenic pain. Swiss Med Wkly. 2003, 133: 170-177.PubMed Tobinick E, Britschgi-Davoodifar S: Perispinal TNF-alpha inhibition for discogenic pain. Swiss Med Wkly. 2003, 133: 170-177.PubMed
29.
go back to reference Karppinen J, Korhonen T, Malmivaara A: Infliximab, used to manage severe sciatica. Spine. 2003, 28: 750-754. 10.1097/00007632-200304150-00004.PubMed Karppinen J, Korhonen T, Malmivaara A: Infliximab, used to manage severe sciatica. Spine. 2003, 28: 750-754. 10.1097/00007632-200304150-00004.PubMed
30.
go back to reference Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, et al: The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine. 2006, 31: 2759-2766. 10.1097/01.brs.0000245873.23876.1e.CrossRefPubMed Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, et al: The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine. 2006, 31: 2759-2766. 10.1097/01.brs.0000245873.23876.1e.CrossRefPubMed
31.
go back to reference Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier CC, Griffith S, et al: A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology. 2007, 107: 99-105. 10.1097/01.anes.0000267518.20363.0d.CrossRefPubMed Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier CC, Griffith S, et al: A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology. 2007, 107: 99-105. 10.1097/01.anes.0000267518.20363.0d.CrossRefPubMed
32.
go back to reference Kary S, Burmester GR: Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Int J Clin Pract. 2003, 57: 231-234.PubMed Kary S, Burmester GR: Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Int J Clin Pract. 2003, 57: 231-234.PubMed
33.
go back to reference Le Maitre CL, Freemont AJ, Hoyland JA: A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol. 2006, 87: 17-28. 10.1111/j.0959-9673.2006.00449.x.PubMedCentralCrossRefPubMed Le Maitre CL, Freemont AJ, Hoyland JA: A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol. 2006, 87: 17-28. 10.1111/j.0959-9673.2006.00449.x.PubMedCentralCrossRefPubMed
Metadata
Title
Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile
Authors
Christine Lyn Le Maitre
Judith Alison Hoyland
Anthony J Freemont
Publication date
01-08-2007
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2275

Other articles of this Issue 4/2007

Arthritis Research & Therapy 4/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.